摘要: 目的:研究表没食子儿茶素没食子酸酯(epigallocatechin-3-gallate, EGCG)对舌鳞癌细胞CAL-27的表皮生长因子受体(epidermal growth factor receptor, EGFR)、相对分子质量为67 000的层粘连蛋白受体(67 000 dalton laminin receptor,67LR)及血管内皮生长因子(vascular endothelial growth factor receptor, VEGF)表达的影响,从而揭示EGCG抑致舌鳞癌细胞增殖的可能机制。方法:不同浓度EGCG处理CAL-27细胞24h后,MTT法检测细胞增殖活性;Real Time PCR法和Western Blot法分别检测CAL-27细胞EGFR、67LR、VEGF的mRNA及蛋白表达情况;Western Blot法检测磷酸化EGFR(p-EGFR)的蛋白表达水平。结果:EGCG浓度依赖性抑制CAL-27细胞的增殖,且抑制其EGFR、67LR、VEGF的mRNA和蛋白、p-EGFR的蛋白表达。结论:EGCG能影响EGFR、67LR及VEGF的转录和翻译水平以及p?鄄EGFR蛋白表达,这可能是EGCG抑制舌鳞癌细胞CAL-27增殖的重要机制。
关键词:
表没食子儿茶素没食子酸酯,
舌鳞癌细胞,
表皮生长因子受体,
层粘连蛋白受体,
血管内皮生长因子
Abstract: Objective: This study was designed to detect the effect of epigallocatechin-3-gallate (EGCG) on the expression of EGFR, 67LR and VEGF in human tongue squamous cell carcinoma cell line CAL-27, and the role of proliferation inhibition to cancer cells. Methods: Human tongue squamous cell carcinoma cell line CAL-27 were treated with EGCG for 24h. Cell viability was assessed by MTT assay. The mRNA levels of EGFR, 67LR and VEGF were measured by real- time PCR and their protein levels were determined by Western Blot. The protein expression of p-EGFR were evaluated by Western Blot. Results: EGCG showed inhibition effect on CAL-27 cells proliferation. Suppression effect of the mRNA levels and protein levels of EGFR, 67LR and VEGF, protein levels of p-EGFR were manifested in a dose-dependent manner. Conclusion: EGCG inhibited the mRNA and protein expression of EGFR, 67LR and VEGF, as well as protein levels of p-EGFR, which may be associated with its suppression effect of proliferation of CAL-27 cells.
Key words:
epigallocatechin-3-gallate, tongue squamous cell carcinoma cell, EGFR,
67 000 dalton laminin receptor(67LR), VEGF
中图分类号:
陈丽莉,苏俭生. EGCG对舌鳞癌细胞CAL-27的EGFR、67LR及VEGF表达的影响[J]. 《口腔颌面外科杂志》, 2012, 22(4): 238-241.
CHEN Li-li,SU Jian-sheng. Effect of Epigallocatechin-3-Gallate on the Expression of EGFR, 67LR and VEGF in Human Tongue Squamous Cell Carcinoma Cell Line CAL-27[J]. 《Journal of Oral and Maxillofacial Surgery》, 2012, 22(4): 238-241.